
usd pm et
summari compani largest pharmaci health care provid
nm price-to-earnings oper ep
past perform indic futur perform reli upon
analysi prepar equiti analyst
pm stock trade
expect sale rise driven
acquisit aetna segment
analysi muddi silverscript
busi move new
benefit hcb segment acquir
pharmaci oper aetna
consolid pbm busi
debt taken merger
suspend share repurchas program
dividend increas compani
achiev leverag ratio debt trail
post-merg leverag ratio approxim
commit lower
end strong free cash
flow gener aet expect
increas billion
compar increas
earli began test first
remodel store health hub texa
store expand health care
servic offer aim help patient
avoid hospit better manag
health think initi perform
learn pilot store
import expect manag
provid updat june
present dour outlook
multitud strong expect
long-term care busi remain
convinc share trade
ep significantli under-valued
trade low end five-year price-to-earnings rang
think cvs-aet
combin tremend upsid potenti
aet rapidly-grow
exposur medicar advantag plan
plan redesign in-stor experi
perspect underwhelm
pbm headwind also
transit year
invest heavili integr aet
streamlin health care deliveri
initi digit health
long-term valu perspect remain
optimist share
risk recommend price includ
integr difficulti failur improv
patient care increas industri regul
target
ep
risk assess reflect compani leadership
posit strong market share rel stabl
 retail drug industri pharmaci benefit
manag pbm somewhat off-set
acquisition-integr risk elev debt level
growth non-tradit competitor
fiscal year end dec ep estim base cfra
oper earn histor earn report
stk
dividend paid sinc compani report
past perform indic futur perform
reli upon
forecast reliabl indic futur perform
redistribut reproduct prohibit without written permiss copyright cfra document intend provid person invest advic take account specif invest
object financi situat particular need specif person may receiv report investor seek independ financi advic regard suitabl and/or appropri make
invest implement invest strategi discuss document understand statement regard futur prospect may realiz investor note incom
invest may fluctuat valu invest may rise fall accordingli investor may receiv back less origin invest investor seek advic concern impact
invest may person tax posit tax advisor pleas note public date document may contain specif inform longer current use make
invest decis unless otherwis indic intent updat document
gener counsel
corpor overview health corpor oper one largest drug store chain
pharmaci benefit manag base revenu net incom store count drug store offer
prescript drug wide assort gener merchandis includ over-the-counter drug beauti product
cosmet film photo finish servic season merchandis greet card conveni
servic plan design administr formulari manag claim process report
segment retail/ltc long-term care segment pharmaci servic segment pbm
acquisit insur aetna aet also oper one largest insur
 fall health benefit hcb segment establish acquisit
aet acquisit aet also result silverscript busi move hcb segment
acquir pharmaci oper aet consolid pharmaci servic busi
market profil decemb oper retail locat approxim
walk-in health care clinic lead pharmaci benefit manag million plan
member oper state district columbia puerto rico brazil fill
billion prescript billion fill retail/ltc segment account
 retail pharmaci market
pharmaci servic segment provid full rang pharmaci benefit manag pbm servic
includ oper mail order pharmaci specialti pharmaci medicar part servic
formulari manag discount drug purchas agreement busi gener billion
sale billion oper incom part pharmaci servic segment
specialti pharmaci busi oper retail specialti pharmaci store specialti mail order
pharmaci mail servic pharmaci
retail/ltc segment gener revenu billion oper incom million
retail/ltc segment revenu compris pharmaci retail segment revenu
front store revenu front store categori includ over-the-count
drug beauti product cosmet person care product conveni food among
product proprietari brand product account approxim compani front store
revenu also one largest oper retail health care clinic clinic
diagnos treat minor health condit perform health screen monitor chronic condit
hcb segment lead health care benefit provid serv estim million
peopl decemb health benefit segment offer broad rang tradit
voluntari consumer-direct health insur product relat servic includ medic
pharmaci dental behavior health medic manag capabl medicar advantag medicar
administr servic health inform technolog hit product servic
corpor strategi pharmaci servic busi strategi center provid innov tool
strategi well qualiti client servic help improv clinic outcom client plan
member assist better pharmaci manag overal health care cost aim
leverag expertis core pbm servic includ plan design offer administr
formulari manag medicar part servic mail order specialti pharmaci infus servic
diseas manag servic medic spend manag
one key retail pharmaci busi strategi technolog allow focu
constantli improv servic explor way provid person product offer
servic continu leverag digit tool empow custom patient make full
breadth health care pharmaci servic avail anytim anywher also continu
introduc digit tool make easier peopl save time money live healthier live
roll pay nationwid end-to-end mobil payment solut integr
payment prescript pick-up extracar loyalti program one spot checkout
impact major develop agre acquir third largest health insur
aetna aet total enterpris valu billion decemb combin close
late make strateg sens us provid greater abil incent aetna larg
popul health plan particip util caremark mail order system retail store
financi trend sale grew five-year compound annual growth rate compound-annual-growth-rate
billion year end decemb adjust ep grew slightli higher five-year compound-annual-growth-rate
free cash flow measur cash flow oper less capit expenditur billion
billion billion decemb net
debt capit ratio expect compani focu reduc immens free
redistribut reproduct prohibit without prior written permiss copyright cfra
base cfra proprietari quantit model
stock rank overvalu
neutral sinc februari technic indic
neutral
figur base fiscal year-end price
growth rate averag
lt debt capit
return equiti
balanc sheet data million usd
oper
long term debt capit
net incom revenu
return asset
return equiti
 global market intellig data may preliminari restat result discontinu operations/speci item per share data adjust stock dividend ep dilut
redistribut reproduct prohibit without prior written permiss copyright cfra
individu mandat passag
tax cut job act decemb
see develop neg health
care servic servic fewer custom
like enrol insur plan start
fewer patient insur uncompens
care rate could rise hospit health
care facil lead lower profit
lower demand supplement health care
pharmaci benefit manag pbm
hurt recent lower level drug price
inflat increas pressur third
parti payer partial allevi high
util pbm merg insur
off-set pressur notabl health
acquir aetna aet ci
major pbm integr
major insur potenti threat
power entiti amazon
recent enter health care
 health servic index
increas vs decreas
fundament outlook health care
servic sub-industri next month
neutral sub-industri perform well
last quarter strength
 economi result lower
number uninsur individu better health
care coverag higher employ strong
economi also led shortag labor
health care servic long run
think health care servic
continu benefit modestli age
popul increas focu
prevent care offset posit
trend continu pressur reduc
cost health care system
wave support democrat parti
novemb mid-term elect
result democrat take control
hous repres increas
medicaid coverag sever state
increas coverag boon health care
servic mani democrat appear run
medicar platform
would like lower averag rate
anoth headlin risk potenti repeal
afford act judg
texa rule unconstitut
oppon appeal decis
current expect upheld upon
appeal although decis could take
coupl year reach
repeal expect impact would neg
health care servic less
health care facil benefit
increas insur coverag
past sever year also
democrat control hous
repres expect
seriou attempt republican repeal
republican success elimin
base index
five-year market price perform
note sector sub-industri inform base
past perform indic futur perform
reli upon
laboratori corpor america
yield equiti
ltd
peer group compani stock select issu base market capit
note peer select base global industri classif standard market capit peer group list includ compani similar characterist may includ compani within
industri and/or engag line busi
redistribut reproduct prohibit without prior written permiss copyright cfra
doj approv -aet merger multipl still lower end
five-year forward pe rang uncertain drug price
environ among pressur share dip midday thursday
primarili news plan departur arrang cfo combin
entiti shawn guertin aet current cfo guertin seen key person
ensur smooth transit integr two entiti intend resign
june person famili reason despit loss guertin still
see signific strateg valu combin entiti /kevin huang cfa
corpor maintain target
ep estim multipl near low end
rang see valuat still hurt intens industri
drug reimburs pressur weak in-stor traffic trend ep
vs higher estim maintain ep
rais ep sale increas
billion same-stor prescript volum grew took
billion goodwil impair charg quarter relat long-term
care busi omnicar pressur facil client
earn call manag highlight drug rebat would like
account million ep opinion
reduc risk drug price chang could result on-going
discuss trump administr pharmaceut manufactur
et cfra keep buy opinion share
corpor take
larger role on-line pharmaci space agre acquir on-line retail
pillpack today acquisit could provid toehold pharmaci
benefit manag pbm retail drug space howev think
signific size scale provid substanti barrier overcom
potenti disrupt establish industri could take
time believ market initi reaction pillpack
acquisit agreement may overblown /kevin huang cfa
analyst research note compani news
et cfra add corp high-qual capit
appreci portfolio think neg sentiment
around medicare-for-al amazon disrupt higher drug price push
share warrant creat entri point follow
cvss recently-issu weak outlook think manag reset
expect enhanc futur upsid view long-term like
cvs/aet tie-up could potenti upsid combin entiti
given higher exposur medicar advantag plan in-stor redesign
plan pharmaci custom forward ep estim share
near low end cvss rang think
limit downsid replac ba high-qual capit
appreci portfolio follow ethiopian plane crash although
think alter long-term prospect ba see chanc increas
share volatil short term news flow relat
investig crash ground ba fleet david
et cfra maintain strong buy opinion share
corpor lower target
ep estim multipl near low
end rang persist industry-wid drug reimburs
pressur ep vs lower estim
lower ep initi ep
share trade morn like disappoint ep
guidanc guidanc significantli expect
surpris conserv estim critic
transit year year invest heavili integr aet
streamlin health care deliveri initi digit health
weve reduc target price reflect headwind
continu believ share under-valued especi given
compani robust cash flow gener long-term valu creat
cvs-aet merger /kevin huang cfa
pm et cfra add share health corpor top
portfolio think -aet combin
tremend upsid potenti aet rapidli grow exposur
medicar advantag plan plan redesign in-stor experi
pharmaci custom merger also elimin risk lose aet
busi revenu enabl incentiv aet
million health plan particip use servic share
current trade ep estim appear discount us
replac ew top portfolio
et cfra reiter strong buy opinion share
health corpor lift target
ep estim multipl near
low end rang persist industry-wid drug
reimburs pressur ep vs lower
estim lift ep keep ep
outlook unchang quarter progress mostli expect
sale increas billion same-stor prescript volum grew
front store store sale increas quarter driven
consum health care beauti care categori manag expect close
merger aetna prior thanksgiv nov plan
achiev two-year synergi exce origin goal million
primarili come lower corpor expens oper integr
medic cost reduct expect first concept store offer new
program servic run earli /kevin huang cfa
buy buy lift target
next-twelve-month ep estim rais valuat
see certain profit futur yesterday
note research note reflect cfra publish opinion analysi stock time note publish note reflect view equiti analyst date time
indic note may reflect cfra current view compani
redistribut reproduct prohibit without prior written permiss copyright cfra
fiscal year analyst estim earn
usd fiscal year analyst estim
earn per share grow usd
total
estimate
forecast reliabl indic futur perform
note compani earn outlook play major part invest decis global market intellig organ earn estim wall street analyst
provid consensu earn next two year well earn estim chang time note inform provid relat consensu
estim intend predict actual result taken reliabl indic futur perform
note tabl graph chart report cite refer sourc sourc global market intellig
redistribut reproduct prohibit without prior written permiss copyright cfra
sinc januari cfra equiti fund research servic
predecessor capit iq equiti research rank univers
common stock adr american depositari receipt adss american
depositari share base given equiti potenti futur perform
similarli rank asian european equiti sinc june
rank equiti accord individu forecast equiti futur total
return potenti versu expect total return relev benchmark
region index asia europ
base time horizon star design meet need
investor look put invest decis perspect data use
assist determin star rank may result analyst
model well intern proprietari model result dynam data
also known
 growth
stabil earn dividend deem key element establish
global market intellig earn dividend rank common stock
design capsul natur record singl symbol
note howev process also take consider certain
adjust modif deem desir establish rank
final score stock measur score matrix determin
analysi score larg repres sampl stock
rang score array sampl align follow
ladder rank
cfra earn per share ep estim reflect analyst project futur
ep continu oper gener exclud variou item
view special non-recur extraordinari also ep estim reflect
either forecast equiti analyst consensu averag ep estim
independ compil global market intellig data
provid cfra among item typic exclud ep estim
asset sale gain impair restructur merger-rel charg legal
insur settlement process research develop expens gain
loss extinguish debt cumul effect account
chang earn relat oper classifi
compani discontinu inclus item stock option
expens recur type charg may vari depend
factor industri practic analyst judgment extent
type data disclos compani
equiti analyst project market price given secur command
month henc base combin intrins rel privat
cfra equiti research produc distribut account research
analyt llc d/b/a cfra cfra us togeth affili
subsidiari cfra certain research produc distribut cfra
sdn bhd compani formerli known standard poor
malaysia sdn bhd cfra malaysia certain research distribut cfra uk
limit cfra uk cfra uk cfra malaysia wholly-own subsidiari
cfra us
abbrevi use equiti research report
ebit earn interest tax
redistribut reproduct prohibit without prior written permiss copyright cfra
p/nav price net asset valu ratio price-to-earnings-to-growth ratio pv present
 research develop roce return capit employ roe
return equiti
roi return invest
 return invest capit
roa return asset
wacc weight averag capit
dividend american depositori receipt adr american depositori
share adss net tax paid countri origin
reflect equiti analyst view given compani oper risk
risk firm abil continu on-going concern qualit risk
assess rel rank star univers
reflect risk factor relat compani oper oppos risk
volatil measur associ share price etf reflect
capitalization-weight basi averag qualit risk assess
assign hold fund
star rank system definit
total return expect outperform total return relev benchmark
notabl margin come month share rise price
total return expect outperform total return relev benchmark
come month share rise price absolut basi
total return expect close approxim total return relev
benchmark come month share gener rise price
absolut basi
total return expect under-perform total return relev
benchmark come month share price anticip
total return expect under-perform total return relev
benchmark notabl margin come month share fall
price absolut basi
north america relev benchmark europ
asia relev benchmark europ asia
